BridgeBio Oncology Therapeutics, Inc. Common Stock

BBOT XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

660M

Short interest (May 15)

4.1%

Borrow Fee

1.76%

↑ 0.8%

Available Shares

↓ 9.9%

Price Chart

Company Overview

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001869105

Asset Type: CS

Market Data

Market Cap: $662,485,750

Employees: 106

Status: Active

Short Interest

Current Borrow Fee 1.76%

Range: 1.76% - 1.87%

Available Shares 4M

Range: 3.8M - 4.1M

Recent Changes

Fee Change: ↑ 6.4%

Available Change: ↑ 48.2%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime